{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:13:56Z","timestamp":1783944836530,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clgc.2026.102587","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:50:56Z","timestamp":1779925856000},"page":"102587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological Predictors of Survival After Radical Nephroureterectomy for UTUC: A Propensity Score-Matched Multicenter Analysis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-9867","authenticated-orcid":false,"given":"Fesih","family":"Ok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Izol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagr\u0131","family":"Akpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-0960","authenticated-orcid":false,"given":"Murat","family":"Gulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-486X","authenticated-orcid":false,"given":"Ata","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Sozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-3186","authenticated-orcid":false,"given":"Ahmet","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Muezzinoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clgc.2026.102587_bib0001","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.eururo.2025.02.023","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update","volume":"87","author":"Masson-Lecomte","year":"2025","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102587_bib0002","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clgc.2026.102587_bib0003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MOU.0000000000001242","article-title":"Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations","volume":"35","author":"Clark","year":"2025","journal-title":"Curr Opin Urol"},{"issue":"8","key":"10.1016\/j.clgc.2026.102587_bib0004","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.21037\/tau-22-882","article-title":"Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review","volume":"12","author":"Grob","year":"2023","journal-title":"Transl Androl Urol"},{"issue":"7","key":"10.1016\/j.clgc.2026.102587_bib0005","doi-asserted-by":"crossref","first-page":"E219","DOI":"10.5489\/cuaj.9039","article-title":"Open, laparoscopic, and robotic radical nephroureterectomy for upper tract urothelial carcinoma comparing outcomes and the tetrafecta as a composite marker of surgery quality","volume":"19","author":"Sandberg","year":"2025","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clgc.2026.102587_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1164464","article-title":"Risk factors for extraurothelial recurrence in upper tract urothelial carcinoma after radical nephroureterectomy: a retrospective study based on a Chinese population","volume":"13","author":"Luo","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.clgc.2026.102587_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1012292","article-title":"Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China","volume":"12","author":"Gao","year":"2022","journal-title":"Front Oncol"},{"issue":"22","key":"10.1016\/j.clgc.2026.102587_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14222491","article-title":"Multi-Centre Study of progression factors and intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract","volume":"14","author":"Garc\u00eda-Morales","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.clgc.2026.102587_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.766576","article-title":"Factors predicting oncological outcomes of radical nephroureterectomy for upper tract urothelial carcinoma in Taiwan","volume":"11","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102587_bib0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0197-2456(00)00104-5","article-title":"Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates","volume":"21","author":"Hsieh","year":"2000","journal-title":"Control Clin Trials"},{"issue":"6","key":"10.1016\/j.clgc.2026.102587_bib0011","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4111\/icu.2019.60.6.432","article-title":"Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma","volume":"60","author":"Kim","year":"2019","journal-title":"Investig Clin Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102587_bib0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1590\/s1677-5538.ibju.2020.1032","article-title":"Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis","volume":"48","author":"Sharma","year":"2022","journal-title":"Int Braz J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102587_bib0013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/JU.0000000000002799","article-title":"Survival impact of variant histology diagnosis in upper tract urothelial carcinoma","volume":"208","author":"Nogueira","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102587_bib0014","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00345-024-04878-6","article-title":"Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy","volume":"42","author":"Song","year":"2024","journal-title":"World J Urol"},{"issue":"10","key":"10.1016\/j.clgc.2026.102587_bib0015","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.21037\/tau-20-1472","article-title":"Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review","volume":"10","author":"Giudici","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"19","key":"10.1016\/j.clgc.2026.102587_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17193226","article-title":"Adjuvant chemotherapy and immunotherapy in upper tract urothelial carcinoma: where do we stand?","volume":"17","author":"Carbunaru","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.clgc.2026.102587_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijsu.2019.04.013","article-title":"Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: a retrospective cohort study","volume":"66","author":"Song","year":"2019","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.clgc.2026.102587_bib0018","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","article-title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy","volume":"112","author":"Xylinas","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2026.102587_bib0019","first-page":"101107","article-title":"Renal function decline after radical nephroureterectomy: longitudinal analysis and predictive factors in upper tract urothelial carcinoma","volume":"46","author":"Chao","year":"2026","journal-title":"Cancer Treat Res Commun"},{"issue":"10","key":"10.1016\/j.clgc.2026.102587_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17101668","article-title":"New insights into upper tract urothelial carcinoma: lessons learned from the ROBUUST Collaborative study","volume":"17","author":"Biasatti","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.clgc.2026.102587_bib0021","doi-asserted-by":"crossref","first-page":"518","DOI":"10.23736\/S2724-6051.22.04659-6","article-title":"Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis","volume":"74","author":"Wu","year":"2022","journal-title":"Minerva Urol Nephrol"},{"key":"10.1016\/j.clgc.2026.102587_bib0022","article-title":"Neoadjuvant chemotherapy for high-risk localized upper tract urothelial carcinoma: final long-term outcomes from a phase 2 clinical trial and an expanded cohort","author":"Jayalath","year":"2025","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102587_bib0023","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00345-024-05267-9","article-title":"Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper tract Urothelial carcinoma treated with nephroureterectomy: real-world data from the ROBUUST 2.0 Registry","volume":"42","author":"Tuderti","year":"2024","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102587_bib0024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00345-023-04700-9","article-title":"Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"42","author":"Chen","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2026.102587_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1031774","article-title":"The lowest level of tumor involvement is a significant prognostic factor for upper tract urothelial carcinoma after radical nephroureterectomy: a large retrospective cohort study","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102587_bib0026","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jfma.2013.11.004","article-title":"Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience","volume":"113","author":"Fang","year":"2014","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.clgc.2026.102587_bib0027","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/diagnostics10040201","article-title":"Tumor multifocality is a significant risk factor of urinary bladder recurrence after nephroureterectomy in patients with upper tract urothelial carcinoma: a single-institutional study","volume":"10","author":"Chen","year":"2020","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.clgc.2026.102587_bib0028","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.21037\/tau-21-758","article-title":"Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study","volume":"10","author":"Zeng","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"3-4","key":"10.1016\/j.clgc.2026.102587_bib0029","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000511650","article-title":"Bladder cancer Study Group of Association of Urooncology, Turkey. The effect of diagnostic ureterorenoscopy on intravesical recurrence in patients undergoing nephroureterectomy for primary upper tract urinary carcinoma","volume":"105","author":"\u0130zol","year":"2021","journal-title":"Urol Int"},{"issue":"2","key":"10.1016\/j.clgc.2026.102587_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000517789","article-title":"Prognostic analysis of diagnostic ureteroscopic biopsy for intravesical recurrence of upper urinary tract urothelial carcinoma","volume":"106","author":"Chen","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2026.102587_bib0031","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4274\/uob.galenos.2019.1432","article-title":"The effect of tumor localization and clinicopathological factors on intravesical recurrence and survival in primary upper urinary tract urothelial tumors","volume":"19","author":"\u0130zol","year":"2020","journal-title":"Bull Urooncol"},{"issue":"9","key":"10.1016\/j.clgc.2026.102587_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2024.04.021","article-title":"Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: a multi-institutional collaborative analysis (ROBUUST collaborative group)","volume":"42","author":"Ditonno","year":"2024","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102587_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2024.10.035","article-title":"The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: a systematic review and meta-analysis","volume":"43","author":"Moretto","year":"2025","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102587_bib0034","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.21037\/tau-23-236","article-title":"Single instillation intravesical chemotherapy after radical nephroureterectomy for upper tract urothelial carcinoma: current evidence and future directions","volume":"12","author":"Refugia","year":"2023","journal-title":"Transl Androl Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732600087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732600087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:52:30Z","timestamp":1783943550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876732600087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S155876732600087X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102587","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological Predictors of Survival After Radical Nephroureterectomy for UTUC: A Propensity Score-Matched Multicenter Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102587"}}